It has been suggested that IL-17 is capable of amplifying the inflammatory cascade and pancreatic damage via regulating the expression of inflammatory molecules and chemokines, as well as recruiting neutrophils and macrophages to the site of injury/inflammation during the pathogenesis of AP in vivo and in vitro (45, 57). This evidence concerns the gene IL17A and alkaline phosphatase measurement.